Please assess the completion status of the following clinical trial:

Trial Title: N-Acetyl Cysteine in Trichotillomania

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* men and women age 18-65;~* current DSM-IV trichotillomania~Exclusion Criteria:~* unstable medical illness;~* history of seizures;~* myocardial infarction within 6 months;~* current pregnancy or lactation, or inadequate contraception in women of childbearing potential;~* any thoughts of suicide;~* lifetime history of DSM-IV bipolar disorder type I, dementia, or schizophrenia or any other DSM-IV psychotic disorder;~* previous treatment with N-Acetyl Cysteine;~* treatment with investigational medication or depot neuroleptics within 3 months, with fluoxetine within 6 weeks, or with other psychotropics within 2 weeks prior to study baseline;~* 9) diagnosis of asthma

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- N-Acetyl Cysteine (Type: ACTIVE_COMPARATOR): N-Acetyl Cysteine
- 2 (Type: PLACEBO_COMPARATOR): Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).